The news regarding Coronavirus Disease 2019 (COVID-19) continues to develop so fast that it may be hard to keep up. The Center for U.S. Policy’s COVID-19 resource page is designed to provide a central location for COVID-19-related updates of greatest relevance to our mission, activities, and collaborating organizations.
Help CUSP keep this information current.
Email us at email@example.com with updates.
April 6, 2020: The National Institute on Drug Abuse (NIDA) published COVID-19: Potential Implications for Individuals with Substance Use Disorders.
April 3, 2020: Aimed Alliance summarized the federal government’s recommendation that Americans wear cloth masks when they leave the house.
April 1, 2020: The Foundation for Opioid Responses Efforts published a legal opinion letter from DCBA Law & Policy regarding prescribing buprenorphine for opioid use disorder during the COVID-19 public health emergency.
March 31, 2020: DEA expanded guidance on using telemedicine for substance use disorder treatment during the COVID-19 pandemic.
March 30, 2020: Aimed Alliance analyzed CMS waivers and guidance providing additional flexibility for ambulances and dialysis clinics in response to the COVID-19 pandemic.
March 25, 2020: Aimed Alliance summarized key provisions of the Coronavirus Aid, Relief, and Economic Security (CARES) Act.
March 24, 2020: Aimed Alliance analyzed guidance released by CMS regarding prescription refills during the COVID-19 pandemic.
March 21, 2020: The U.S. Food and Drug Administration announced a new program to expedite the development of treatments for COVID-19.
March 20, 2020: The Milken Institute, a non-profit thinktank, launched a COVID-19 vaccine and treatment tracker.
March 16, 2020: The Substance Abuse and Mental Health Services Administration (SAMHSA) provided guidance on treatment availability for those with substance use disorders during the COVID-19 pandemic.
March 15, 2020: Faces & Voices of Recovery published COVID-19-related statements from prominent 12 step and mutual aid groups.